Operating Expenses

Defined Contribution Plan Cost

Vertex Pharmaceuticals Defined Contribution Plan Cost remained flat by 0.0% to $15.78M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.7%, from $13.08M to $15.78M. Over 2 years (FY 2023 to FY 2025), Defined Contribution Plan Cost shows an upward trend with a 20.3% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026
Metric ID: ibm_defined_contribution_plan_cost

Historical Data

3 years
 FY'23FY'24FY'25
Value$43.60M$52.30M$63.10M
YoY Change—+20.0%+20.7%
Range$43.60M – $63.10M
CAGR+20.3%
Avg YoY Growth+20.3%
Median YoY Growth+20.3%
Current Streak2+ years growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's defined contribution plan cost?
Vertex Pharmaceuticals (VRTX) reported defined contribution plan cost of $15.78M in Q4 2025.
How has Vertex Pharmaceuticals's defined contribution plan cost changed year-over-year?
Vertex Pharmaceuticals's defined contribution plan cost increased by 20.7% year-over-year, from $13.08M to $15.78M.
What is the long-term trend for Vertex Pharmaceuticals's defined contribution plan cost?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's defined contribution plan cost has grown at a 20.3% compound annual growth rate (CAGR), from $43.60M to $63.10M.